RBCL — RBC Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for RBC Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2010 December 31st	2011 December 31st	C2012 December 31st	2013 December 31st	C2014 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-Q	10-K	10-Q
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4.22	3.86	3.9	3.75	1.92
Net Total Accounts Receivable
Net Total Receivables	0.492	0.586	0.877	0.907	1.29
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11.3	12	11.2	11	8.85
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.64	4.49	4.49	4.17	4.68
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	18.3	18.8	18	17.5	16
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.75	6.41	6.03	6.66	6.11
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	8.47	8.96	8.5	8.52	7.57
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.88	9.86	9.52	9.01	8.43
Total Liabilities & Shareholders' Equity	18.3	18.8	18	17.5	16
Total Common Shares Outstanding